Windlas Biotech Ltd Annually Results

Gross Sales

630.96

513.08

465.93

427.6

328.85

Excise Duty

0

0

0

0

0

Net Sales

630.96

513.08

465.93

427.6

328.85

Other Operating Income

0

0

0

0

0

Other Income

13.47

9.97

6.71

8.74

2.49

Total Income

644.42

523.05

472.64

436.34

331.34

Total Expenditure

552.78

452.86

413.51

400.35

294.85

PBIDT

91.64

70.19

59.13

36

36.49

Interest

1.11

0.79

1.42

1.29

2.53

PBDT

90.54

69.4

57.71

34.71

33.96

Depreciation

13.44

12.36

12.15

12.97

9.29

Minority Interest Before NP

0

0

0

0

0

Tax

17.37

14.35

10.13

4.84

8.57

Deferred Tax

1.54

0.06

-2.66

1.33

-0.12

Reported Profit After Tax

58.19

42.63

38.09

15.57

16.21

Minority Interest After NP

0

0

0

-0.26

0

Net Profit after Minority Interest

58.19

42.63

38.09

15.83

16.21

Extra-ordinary Items

0

0

0

-15.48

0

Adjusted Profit After Extra-ordinary item

58.19

42.63

38.09

31.31

16.21

EPS (Unit Curr.)

27.97

19.7

18.58

8.7

8.9

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

110

80

70

0

0

Equity

10.4

10.46

10.9

6.41

6.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.52

13.68

12.69

8.41

11.09

PBDTM(%)

14.34

13.52

12.38

8.11

10.32

PATM(%)

9.22

8.3

8.17

3.64

4.92